The viral vector and plasmid DNA manufacturing market is one of the fastest growing global biotechnology segments. Pegged at $321.3 million in 2017, the market is expected to reach $1.1 billion by ...

Lentiviral vectors are one of the foundational technologies of cell and gene therapy. Along with adenoviral vectors, they are one of the most widely used means of introducing genetic information into ...

As a lab within the Cooperative Center of Excellence in Hematology (CCEH) at Fred Hutch, the Vector Production core assists investigators with the design, construction, and/or production of viral ...

Companies across every industry increasingly understand that making data-driven decisions is a necessity to compete now, in the next five years, in the next 20 and beyond. Data growth — unstructured ...